Source: Pharmaceutical Processing

Paragonbioteck: Paragon BioTeck Reformulates Freshkote, Prompting Eyevance Acquisition

NewsThe company recently completed the reformulation for the Freshkote family of lubricant eye drops, purchased last week by Eyevance Pharmaceuticals.Contributed Author: Paragon BioTeckTopics: Pharmaceutical Processing

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
Patrick Witham's photo - President & CEO of Paragonbioteck

President & CEO

Patrick Witham

CEO Approval Rating

70/100

Read more